Medifast Q2 FY26 net loss widens to $3.1 million; revenue drops 27.6% to $76.4 million

Reuters2026/08/03 20:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Medifast posted Q2 2026 revenue of USD 76.4 million, down 27.6% year over year.
Net results turned to a loss of USD 3.1 million, or USD 0.28 per diluted share.
Active earning coaches fell 48.7% to 11,700, while revenue per active earning coach rose 41% to USD 6,529.
Cash, cash equivalents and investment securities totaled USD 169.8 million at June 30, with no debt.
Forecasts Q3 revenue of USD 60 million to USD 80 million, with loss per share of USD 0.15 to USD 0.65.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medifast Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260803959120) on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Medifast Q2 FY26 net loss widens to $3.1 million; revenue drops 27.6% to $76.4 million

You may also like

Crypto prices